Acrivon Therapeutics, Inc. ACRV

Institutional shares held 22.4 Million

0 calls

0 puts

Total value of holdings $0

$0 calls

$0 puts

Market Cap N/A

Institutional ownership N/A

# of Institutions 58

We take great care to ensure that the data presented and summarized in this overview for Acrivon Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.

Quarterly Institutional Activity in ACRV

Shares Bought

Shares Sold

View Transactions

Top Institutions Holding ACRV

View all

Latest Institutional Activity in ACRV

Top Purchases

Q1 2025

Exchange Traded Concepts, LLC Shares Held: 23.2K ($0)

2.81K Shares purchased

13.82% Added

Q1 2025

Nisa Investment Advisors, LLC Shares Held: 959 ($0)

859 Shares purchased

859.0% Added

Q1 2025

Gf Fund Management Co. Ltd. Shares Held: 772 ($0)

118 Shares purchased

18.04% Added

Q1 2025

Cwm, LLC Shares Held: 49 ($0)

8 Shares purchased

19.51% Added

Q1 2025

Mirae Asset Global Investments Co., Ltd. Shares Held: 1.04K ($0)

4 Shares purchased

0.39% Added

View All Buyers

Top Sells

Q1 2025

Rhumbline Advisers Shares Held: 16.6K ($0)

1.16K Shares sold

6.51% Reduced

Q1 2025

China Universal Asset Management Co., Ltd. Shares Held: 6.25K ($0)

357 Shares sold

5.41% Reduced

Q1 2025

Gamma Investing LLC Shares Held: 287 ($0)

296 Shares sold

50.77% Reduced

Q4 2024

Marshall Wace, LLP Shares Held: 598K ($0)

212K Shares sold

26.19% Reduced

Q4 2024

Citadel Advisors LLC Shares Held: 2.12M ($0)

21K Shares sold

0.98% Reduced

View All Sellers

About ACRV

Insider Transactions at ACRV

Insider Transaction List

View all

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
May 01 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	298,886 -8.78%	$298,886 $1.34 P/Share
Apr 30 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	437,881 -11.4%	$437,881 $1.41 P/Share
Apr 29 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	250,000 -6.11%	$250,000 $1.41 P/Share
Apr 28 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	215,283 -5.0%	$215,283 $1.56 P/Share
Apr 25 2025	Perceptive Advisors LLC > 10% Shareholder	SELL Open market or private sale	Indirect	1,054,669 -19.67%	$1,054,669 $1.95 P/Share
Apr 17 2025	Mary Miller Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	558 -1.51%	$558 $1.81 P/Share
Feb 21 2025	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Direct	19,904 -0.86%	$99,520 $5.54 P/Share
Feb 14 2025	Katharine Peterson Chief Accounting Officer	SELL Payment of exercise price or tax liability	Direct	116 -2.56%	$580 $5.42 P/Share
Feb 14 2025	Rasmus Holm Jorgensen Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	434 -1.64%	$2,170 $5.42 P/Share
Feb 14 2025	Mary Miller Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	217 -0.58%	$1,085 $5.42 P/Share
Feb 14 2025	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Indirect	579 -0.18%	$2,895 $5.42 P/Share
Feb 14 2025	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Direct	37,152 -1.59%	$185,760 $5.42 P/Share
Feb 14 2025	Eric Devroe Chief Operating Officer	SELL Payment of exercise price or tax liability	Direct	724 -1.07%	$3,620 $5.42 P/Share
Feb 14 2025	Erick Gamelin Chief Development Officer	SELL Payment of exercise price or tax liability	Direct	469 -2.77%	$2,345 $5.42 P/Share
Jan 17 2025	Mary Miller Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	659 -1.74%	$3,295 $5.78 P/Share
Nov 21 2024	Peter Blume Jensen President and CEO	SELL Payment of exercise price or tax liability	Direct	19,910 -0.84%	$119,460 $6.44 P/Share
Nov 14 2024	Erick Gamelin Chief Development Officer	SELL Payment of exercise price or tax liability	Direct	402 -2.32%	$2,814 $7.92 P/Share
Nov 14 2024	Rasmus Holm Jorgensen Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	368 -1.37%	$2,576 $7.92 P/Share
Nov 14 2024	Mary Miller Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	184 -0.48%	$1,288 $7.92 P/Share
Nov 14 2024	Katharine Peterson Chief Accounting Officer	SELL Payment of exercise price or tax liability	Direct	99 -2.14%	$693 $7.92 P/Share

View All Transactions

Last 12 Months Summary

Buy / Acquisition

10K Shares

From 1 Insiders

Exercise of conversion of derivative security	10K shares

Sell / Disposition

2.6M Shares

From 8 Insiders

Open market or private sale	2.26M shares
Payment of exercise price or tax liability	343K shares

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Insider Trading

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Acrivon Therapeutics, Inc.

Track Activities on ACRV

Account

Acrivon Therapeutics, Inc. ACRV

Quarterly Institutional Activity in ACRV

Top Institutions Holding ACRV

Latest Institutional Activity in ACRV

Top Purchases

Top Sells

About ACRV

Insider Transactions at ACRV

Insider Transaction List

Last 12 Months Summary

Track Institutional and Insider Activities on ACRV

Institutional Portfolio Updates

Insider Trading

News